Expression and clinical relevance of SPOPL in medulloblastoma

  • Authors:
    • Yuanjun Hu
    • Lixuan Yang
    • Maolei Zhang
    • Zhengsong Huang
    • Jiaping Lin
    • Nu Zhang
  • View Affiliations

  • Published online on: June 30, 2017     https://doi.org/10.3892/ol.2017.6500
  • Pages: 3051-3056
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Medulloblastoma (MB) is a type of malignant brain tumor in children. Although knowledge of MB is increasing and the survival rate of patients with MB has improved in previous years, the long‑term treatment‑associated complications remain unfavorable. Early diagnosis and treatment is critical for patients with MB, but effective molecular markers for MB remain elusive. The Speckle‑type POZ protein (SPOP) is a member of the MATH‑BTB protein family and is a type of joint molecule for Cullin‑3. SPOP inhibits tumor growth. However, the SPOP‑like (SPOPL) gene, which is a SPOP paralog gene and shares an overall 85% sequence identity with SPOP, has not been explored in cancer studies at present. The results of the present study demonstrate that the SPOPL expression is decreased in MB cells and tissues compared with normal cells and tissues at the protein and mRNA levels. Immunohistochemical analysis revealed decreased expression of SPOPL in 42/56 (75%) paraffin‑embedded archival MB biopsies, and SPOPL expression may be associated with the MB differentiation level (P=0.011). Patients with increased SPOPL expression exhibit improved survival rates compared with those with decreased SPOPL expression, and the SPOPL gene may be a potentially valuable molecular marker of MB.
View Figures
View References

Related Articles

Journal Cover

September-2017
Volume 14 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hu Y, Yang L, Zhang M, Huang Z, Lin J and Zhang N: Expression and clinical relevance of SPOPL in medulloblastoma. Oncol Lett 14: 3051-3056, 2017
APA
Hu, Y., Yang, L., Zhang, M., Huang, Z., Lin, J., & Zhang, N. (2017). Expression and clinical relevance of SPOPL in medulloblastoma. Oncology Letters, 14, 3051-3056. https://doi.org/10.3892/ol.2017.6500
MLA
Hu, Y., Yang, L., Zhang, M., Huang, Z., Lin, J., Zhang, N."Expression and clinical relevance of SPOPL in medulloblastoma". Oncology Letters 14.3 (2017): 3051-3056.
Chicago
Hu, Y., Yang, L., Zhang, M., Huang, Z., Lin, J., Zhang, N."Expression and clinical relevance of SPOPL in medulloblastoma". Oncology Letters 14, no. 3 (2017): 3051-3056. https://doi.org/10.3892/ol.2017.6500